Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
45.43
+1.32 (2.99%)
At close: Apr 28, 2026, 4:00 PM EDT
45.43
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:01 PM EDT
Kodiak Sciences Employees
Kodiak Sciences had 124 employees as of December 31, 2025. The number of employees increased by 15 or 13.76% compared to the previous year.
Employees
124
Change (1Y)
15
Growth (1Y)
13.76%
Revenue / Employee
n/a
Profits / Employee
-$1,854,573
Market Cap
2.80B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 647 |
| Tarsus Pharmaceuticals | 370 |
| Vera Therapeutics | 249 |
| Celldex Therapeutics | 198 |
| Relay Therapeutics | 192 |
| Soleno Therapeutics | 182 |
| Immunome | 177 |
| Disc Medicine | 155 |
KOD News
- 10 days ago - Russell 2000 Rips To Record High — Here Are The Top Small Cap Gainers - Benzinga
- 27 days ago - Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 4 weeks ago - Kodiak Sciences: Road To $120 - Forbes
- 4 weeks ago - Kodiak Sciences Stock Is Surging Friday: What's Driving The Action? - Benzinga
- 4 weeks ago - Kodiak Sciences stock soars over 60%: what's behind the sharp rally - Invezz
- 4 weeks ago - Kodiak Sciences shares surge after eye drug succeeds in late-stage study - Reuters
- 4 weeks ago - Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham - PRNewsWire
- 2 months ago - Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026 - PRNewsWire